Michael Shankman

Insider Reports History

Location
406 Natalie Lane, Danville, CA
Signature
/Michael Shankman/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Shankman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexaria Bioscience Corp. Chief Financial Officer Stock Options 100K $122K $1.22 May 15, 2025 Direct

Insider Reports Filed by Michael Shankman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LEXX Lexaria Bioscience Corp. May 15, 2025 1 $0 4 May 16, 2025 Chief Financial Officer
LEXX Lexaria Bioscience Corp. Oct 1, 2024 0 $0 3 Oct 2, 2024 Chief Financial Officer